Learn more

VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG

Overview
  • Total Patents
    133
About

VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG has a total of 133 patent applications. Its first patent ever was published in 2003. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and China. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are ILLUMIGEN BIOSCIENCES INC, GOVERNMENT OF THE REPUBLIC OF and KINETA TWO LLC.

Patent filings per year

Chart showing VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORGs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Snijders Petrus Josephus Ferdinandus 13
#2 Meijer Christophorus Joannes Lambertus Maria 12
#3 Steenbergen Renske Daniela Maria 11
#4 Van Beusechem Victor Willem 10
#5 Meijer Gerrit A 9
#6 Nilsson Rolf Jonas 7
#7 Smits Rogier Adriaan 7
#8 Leurs Regorius 7
#9 Pinto Morais De Carvalho Beatriz 7
#10 Polak Marloes 6

Latest patents

Publication Filing date Title
WO2013070079A2 miRNA IN BLOOD BRAIN BARRIER OF MS PATIENTS
WO2013060881A1 Pyridopyrimidines and their therapeutic use
WO2013051932A1 Molecular manipulation apparatus and method for investigating a plurality of molecules
WO2013025099A1 Substrates for the detection of periopathogens of the oral cavity
WO2013022342A1 A method of analysing a blood sample of a subject for the presence of a foetal disease or condition marker
WO2012165956A1 N,n-substituted guanidine compound
CN103547920A A method of analyzing a blood sample of a subject for the presence of a disease marker
WO2012093939A1 Particles comprising calcium phosphate and use thereof
CA2819538A1 Method for prognosticating the clinical response of a patient to b-lymphocyte inhibiting or depleting therapy in interferon driven diseases such as sle.
WO2012165943A1 A method of analysing a blood sample of a subject for the presence of an infectious disease marker
WO2012005588A2 Novel biomarkers for detecting neuronal loss
WO2012150857A1 Protection against endothelial barrier dysfunction through inhibition of the tyrosine kinase abl-related gene (arg)
EP2534259A1 Method for combined monitoring of detection of at least two molecular targets and to a kit therefore
WO2011103932A1 A process for the preparation of substituted prolyl peptides and similar peptidomimetics
EP2475965A1 Optical fiber, method of preparation thereof and device
WO2011005080A1 Three dimensional tracking system and method
EP2270002A1 Quinazoline derivatives as histamine H4-receptor inhibitors for use in the treatment of inflammatory disorders
EP2283154A1 Mal and cadm1 promoter methylation a molecular diagnostic marker for hpv-induced invasive cervical cancers and their high-grade precursor lesions
EP2239577A1 Protein-based methods and compositions for the diagnosis of colorectal adenocarcinoma
WO2009113859A1 Cervical screening algorithms